| | Participants | Number of comparisons | /T | /C | MD (95% CI) (mmol/L) | P value | (%) | P
heterogeneity |
| | Baduanjin + routine treatment versus routine treatment | | | | | | | | | Clinical patients | 5 | 136 | 136 | 0.04 (−0.1, 0.18) | | 73 | | | Baduanjin versus no treatment | | | | | | | | | Clinical patients | 2 | 38 | 35 | 0.22 (−0.11, 0.55) | | 92 | | | Healthy participants | 9 | 140 | 144 | 0.13 (0.06, 0.21) | | 56 | | | Baduanjin versus other exercises | | | | | | | | | Healthy participants | 2 | 49 | 47 | −0.09 (−0.25, 0.06) | | 19 | | | Baduanjin + routine versus other exercises + routine treatment | | | | | | | | | Clinical patients | 3 | 114 | 106 | 0.00 (−0.06, 0.07) | | 0 | |
|
|